FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

WST

West Pharmaceutical ServicesNYSE · Health Care Supplies · Health Care
Previous close
362.01
Change
−2.99 / −0.82%
FinDog View
Neutral
52-Week Range
223.83 – 386.00
P/E (TTM)
43.1
Forward P/E
36.0
Based on consensus earnings for the next 12 months
Market Cap
$23.9B
1M
+4.44%
S&P 500 −2.41% over same period
Volume / Avg Volume
621K / 541K
1.15× average

Price History

Closing price · USD1M6M1Y5Y
100200300400500FY26 Q2 EarningsFY26 Q1 EarningsFY25 Q4 EarningsFY25 Q3 EarningsFY25 Q2 EarningsFY25 Q1 Earnings2021-092022-122024-032025-062026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 44.41M6M1Y5Y
43444546472026-082026-082026-092026-092026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2026 Q2
Quarter ended 2026-06
2026-07-23$872M2.37 / 2.10−7.67%Pending
FY2026 Q1
Quarter ended 2026-03
2026-04-23$845M2.13 / 1.69−1.14%Pending
FY2025 Q4
Quarter ended 2025-12
2026-02-12—— / —+2.82%Pending
FY2025 Q3
Quarter ended 2025-09
2025-10-23—— / —−3.18%Pending
FY2025 Q2
Quarter ended 2025-06
2025-07-24—— / —−5.59%Pending
FY2025 Q1
Quarter ended 2025-03
2025-04-24—— / —+1.88%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 49 of its 5-year rangeMid-range
5-year range 32.9 – 55.0 · Median 43.2
Last 4 quarters: $454M in buybacks + $62.4M in dividends, 2.16% of market cap combined
P/E (TTM)
43.1
P/B
8.2
P/S
7.3
Dividend Yield
0.33%
Earnings Reaction
Over the last 6 reports, the stock moved ±3.7% on average on the first trading day after, rising 2 times
Most recent −7.67%
Volatility & Correlation
1-year beta 0.62 · Correlation with S&P 500 0.24Low beta
Annualized volatility 34% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 4 · $5.4MNet selling $5.4M
  • 09-15Favorite Annette FSr. VP & Chief HR OfficerSell$0.92M2,524 shares · Avg price 365.00
  • 09-14Favorite Annette FSr. VP & Chief HR OfficerSell$0.89M2,500 shares · Avg price 355.00
  • 09-11Favorite Annette FSr. VP & Chief HR OfficerSell$0.86M2,500 shares · Avg price 345.00
  • 09-08Favorite Annette FSr. VP & Chief HR OfficerSell$2.8M8,135 shares · 3 trades · Avg price 340.81
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q20.87+13.8%37.7%0.180.150.082.15
FY2026 Q10.84+21.0%35.1%0.180.140.051.92
FY2025 Q40.81+7.5%37.8%0.160.130.181.82
FY2025 Q30.80+7.7%36.6%0.170.140.131.92
FY2025 Q20.77+9.2%35.7%0.150.130.101.82
FY2025 Q10.70+0.4%33.2%0.110.090.061.23
FY2024 Q40.75+2.3%36.5%0.160.130.091.78
FY2024 Q30.75−0.1%35.4%0.160.140.101.85
FY2024 Q20.70−6.9%32.8%0.130.110.061.51
FY2024 Q10.70−3.0%33.1%0.120.120.031.55
FY2023 Q40.73+3.3%38.0%0.160.140.131.83
FY2023 Q30.75+8.8%38.6%0.180.160.132.14

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
WSTWest Pharmaceutical Services$23.9B43.1+13.8%37.7%+4.44%Neutral
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare